Adult-onset gastrointestinal malabsorption of the essential micronutrient, cobalamin (vitamin B 12 ), leads to potentially lethal manifestations as diverse as megaloblastic anemia and neutropenia, degeneration of spinal cord nerve tracts, and dementia. 1 In the very young, signs of cobalamin malabsorption may also include growth retardation or loss of developmental milestones or both. ImerslundGräsbeck syndrome (I-GS; also called megaloblastic anemia 1, OMIM no. 261100) is an autosomal recessive disorder characterized by selective malabsorption of cobalamin in the intestine and, most often, of specific low-molecular-weight proteins in renal proximal tubules. 2, 3 Patients with I-GS typically present at 2 to 4 years of age with signs of cobalamin deficiency and proteinuria. More than 200 human cases and familial clusters have been reported in Finland, Norway, the Middle East, and Northern Africa. 1 Various null and missense mutations of the cubilin (CUBN) 4 and amnionless (AMN) genes 5 have been implicated in I-GS kindreds, but both loci have been excluded in some. 6 In addition, a number of patients suffering from gastric intrinsic factor (IF) deficiency have been misdiagnosed as having I-GS. 7 Cubilin is a 460-kDa multiligand receptor protein that mediates endocytosis of the IF-cobalamin complex from distal small intestinal chyme and of several proteins from glomerular filtrate in renal proximal tubules. 8 AMN is an approximately 48-kDa apical membrane protein also expressed in intestinal and proximal tubule epithelia but whose function is poorly defined. 5, 9 Recent studies suggested that cubilin and AMN function as subunits of a receptor complex, now called "cubam." 10 However, no studies have directly assessed the effect of CUBN or AMN mutations on cubam expression in patients with I-GS because these proteins are expressed in inaccessible tissues, and the clinical disease is easily treated. Unfortunately, the AMN knockout mouse exhibits an embryonic lethal phenotype. 9 Canine I-GS was derived originally from purebred giant schnauzers (GSs) as a naturally occurring animal model of the human disorder [11] [12] [13] and has contributed significantly to understanding of its molecular biologic basis as well as aspects of cubilin function. 14-17 CUBN was excluded from the GS disease locus, 18 and the disorder was recently mapped to an approximately 4-Mb interval predicted to harbor AMN. 19 To define the molecular basis of the canine I-GS model, we sought AMN mutations segregating in the GS kindred and an unrelated kindred of Australian shepherd (AS) dogs and investigated in vivo AMN and cubilin expression in affected dogs. Additionally, comparison of these results to expression of mutant canine AMN in a heterologous mammalian-cell transfection system validates the cell-culture system for ex vivo 
Introduction
Adult-onset gastrointestinal malabsorption of the essential micronutrient, cobalamin (vitamin B 12 ), leads to potentially lethal manifestations as diverse as megaloblastic anemia and neutropenia, degeneration of spinal cord nerve tracts, and dementia. 1 In the very young, signs of cobalamin malabsorption may also include growth retardation or loss of developmental milestones or both. ImerslundGräsbeck syndrome (I-GS; also called megaloblastic anemia 1, OMIM no. 261100) is an autosomal recessive disorder characterized by selective malabsorption of cobalamin in the intestine and, most often, of specific low-molecular-weight proteins in renal proximal tubules. 2, 3 Patients with I-GS typically present at 2 to 4 years of age with signs of cobalamin deficiency and proteinuria. More than 200 human cases and familial clusters have been reported in Finland, Norway, the Middle East, and Northern Africa. 1 Various null and missense mutations of the cubilin (CUBN) 4 and amnionless (AMN) genes 5 have been implicated in I-GS kindreds, but both loci have been excluded in some. 6 In addition, a number of patients suffering from gastric intrinsic factor (IF) deficiency have been misdiagnosed as having I-GS. 7 Cubilin is a 460-kDa multiligand receptor protein that mediates endocytosis of the IF-cobalamin complex from distal small intestinal chyme and of several proteins from glomerular filtrate in renal proximal tubules. 8 AMN is an approximately 48-kDa apical membrane protein also expressed in intestinal and proximal tubule epithelia but whose function is poorly defined. 5, 9 Recent studies suggested that cubilin and AMN function as subunits of a receptor complex, now called "cubam." 10 However, no studies have directly assessed the effect of CUBN or AMN mutations on cubam expression in patients with I-GS because these proteins are expressed in inaccessible tissues, and the clinical disease is easily treated. Unfortunately, the AMN knockout mouse exhibits an embryonic lethal phenotype. 9 Canine I-GS was derived originally from purebred giant schnauzers (GSs) as a naturally occurring animal model of the human disorder [11] [12] [13] and has contributed significantly to understanding of its molecular biologic basis as well as aspects of cubilin function. [14] [15] [16] [17] CUBN was excluded from the GS disease locus, 18 and the disorder was recently mapped to an approximately 4-Mb interval predicted to harbor AMN. 19 To define the molecular basis of the canine I-GS model, we sought AMN mutations segregating in the GS kindred and an unrelated kindred of Australian shepherd (AS) dogs and investigated in vivo AMN and cubilin expression in affected dogs. Additionally, comparison of these results to expression of mutant canine AMN in a heterologous mammalian-cell transfection system validates the cell-culture system for ex vivo determination of functional domains in both proteins and defects caused by CUBN and AMN mutations.
Materials and methods

Animals
Dogs were handled according to principles and protocols approved by the MSU All University Committee for Animal Use and Care. MSU University Laboratory Animal Resources housed dogs of the GS kindred. Private owners submitted samples for DNA isolation from dogs of the AS kindred. DNA samples of 80 unrelated healthy dogs of 10 various breeds were a kind gift from V. Yuzbasiyan-Gurkan (MSU). DNA of additional healthy dogs was isolated from anonymous blood samples submitted to the MSU Veterinary Clinical Pathology Laboratory.
Linkage analysis and AMN cDNA cloning gDNA was prepared variously from buccal brushes, blood, or frozen liver by standard methods. 20, 21 Canine sequences of the kinesis 2 gene (KNS2) were obtained from a database of genomic sequence maintained by The Institute for Genomic Research as described previously. 19 Part of KNS2 was amplified from gDNA using polymerase chain reaction (PCR) primers 5Ј-GAGCCTCTGGATGACCTTTTC-3Ј and 5Ј-CACTGCTATGCTGCT-GTTGGACT-3Ј, and a CϾT polymorphism was identified (CFA 8, position 74340382, July 2004 canine genome assembly). KNS2 genotyping was by direct sequencing of PCR products, and linkage analysis was with the FASTLINK software package, version 4.1P (NCBI, Bethesda, MD). [22] [23] [24] DNA was sequenced by automated dideoxy chain termination technology (University of Michigan DNA Sequencing Core Facility, Ann Arbor, MI).
A canine proximal tubule cell cDNA bacteriophage library 25 was screened by pooled PCR selection 26 amplifying a portion of AMN cDNA using primers 5Ј-TCTTCTYCGTGGACGCCGAGCG-3Ј and 5Ј-GGTC-CTCGTCGCGCGWGAACGT-3Ј. After phage purification, clones were rescued into the phagemid pBluescript (Stratagene, La Jolla, CA). Inserts were sequenced completely on both strands and analyzed using Lasergene software (DNAstar, Madison, WI). The full-length canine AMN cDNA sequence was submitted to the EMBL/GenBank Data Libraries (accession no. AY368152).
AMN expression analysis
RNA was isolated and Northern blots were prepared as described previously 13 using a random primed-labeled AMN cDNA probe. AMN expression was examined in various tissues by reverse transcription-coupled PCR (RT-PCR) with PCR primers 5Ј-CGGGCGCGCGGCGGGATG-3Ј and 5Ј-CTGGCCAGCCCCGCGGTTGC-3Ј to amplify the full-length cDNA. Primers for CUBN cDNA (exons 8-12) detection in the same RT reactions were 5Ј-AGCCTGCGTGCTGGACATAGAC-3Ј and 5Ј-CCAGCCCAAC-CTGATTCACACTTA-3Ј and for PPID (peptidyl-prolyl isomerase D, also called cyclophilin D) cDNA (exons 3-7) detection were 5Ј-TCAGGGTG-GAGACTTCTCAAATC-3Ј and 5Ј-GTTGCAGCTTCAGTCTATCTGCT-3Ј.
Anti-canine AMN peptide antisera were produced by immunizing rabbits with synthetic peptides TARESGAPVGDGSA (AMN residues 340-353) and RRAPRLRWTKRER (residues 388-400) in the custom antibody production facilities of ProSci (Poway, CA) under the National Institutes of Health Animal Welfare Assurance (no. A4182-01). IFcobalamin-binding proteins were isolated in the presence of a protease inhibitor cocktail from membrane or supernatant fractions of kidney homogenates 27 produced from tissue that was snap-frozen in liquid nitrogen immediately after the dogs were humanely killed; proteins were stored at Ϫ80°C. Endoglycosidase H (endo H) and peptide N-glycosidase F (PNGase F) digestions were carried out essentially as described previously. 10, 13 Proteins were separated variously by reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) or by 2-dimensional gel electrophoresis (nonlinear pH 3-10 isoelectric focusing and reducing SDS-PAGE on 15% gels). 28 Gels were silver stained 29 or blotted to polyvinylidene difluoride (PVDF) membranes. Immunoblots were incubated as previously described 10, 13 with anti-AMN peptide sera diluted 1:40 000. Secondary antibody was anti-rabbit IgG-alkaline phosphatase conjugate (Sigma, St Louis, MO), and proteins were detected with P-nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate. Specificity of primary antisera was determined on control blots incubated with decreasing concentrations of the primary anti-AMN sera, preimmune sera, sera depleted of specific antibody by peptide affinity chromatography, or secondary antibody only.
Bands or spots separated by SDS-PAGE or 2-dimensional gel electrophoresis and corresponding to immunodetected proteins were subjected to in-gel tryptic digestion followed by liquid chromatography coupled with tandem mass spectrometric peptide mapping (LC/MS/MS) in the Proteomics Core of the MSU Genomics Technology Support Facility, as previously described. 30 Resulting spectra were searched against the NCBInr database, using the Mascot searching algorithm (Matrix Science, Boston, MA) with taxonomy limited to mammals. 31 The respective probability-based molecular weight search (Mowse) scores for the approximately 48-kDa and approximately 40-kDa canine AMN species were 1038 and 657.
Mutation determination
Kidney cortex RNA of dogs was isolated and RT reactions were performed as before. PCR amplification of RT products was with primers described (see "AMN expression analysis") for full-length AMN cDNA amplification or, to examine the translation initiation sequence, with primers 5Ј-CGGGCGCGCGGCGGG-3Ј, the 15 bp immediately 5Ј of the translation initiation codon, and 5Ј-CGCTCGGCGTCCACGGAGAAGA-3Ј in exon 5. cDNA amplification products were sequenced, and putative mutations were confirmed by PCR amplification of gDNA. Screening for the c.1113_1145del allele in the GS kindred and unrelated populations was by PCR amplification of gDNA templates using primers 5Ј-TCCGTTGCAG-GCGAAGCCCTC-3Ј and 5Ј-CTGCGGGGTGCGTGGAACCTAG-3Ј. Allele-specific products were separated by agarose electrophoresis in 2% gels. Screening for the c.3GϾA allele in the AS kindred and unrelated populations was by PCR, using primers 5Ј-GGCTTGGAAGGAAGGC-CCCCA-3Ј and 5Ј-CAAGGCGGGGAGCCTCCGAA-3Ј, followed by BstF5I digestion of the products and electrophoresis of the allele-specific digestion products on 2.5% gels.
Analysis of AMN and cubilin expression in affected dogs in vivo
Membrane and soluble fraction proteins of healthy and GS kindred affected dogs were isolated in parallel, each from 125 g kidney cortex, by IF-cobalamin affinity chromatography as previously described. 10, 27 Oneand 2-dimensional SDS-PAGE gels were prepared and protein bands or spots between 37 and 50 kDa observed on gels of healthy dog proteins, but not on the corresponding gels of affected dog proteins, were identified by LC/MS/MS peptide mapping and Western blotting as described (see "AMN expression analysis").
For biopsy quantities of tissue (Ͻ 1 g), kidney cortex was thawed and homogenized in 9 volumes of cold 50 mM Tris (tris(hydroxymethyl)aminomethane-Cl (pH 7.4) containing 150 mM NaCl, 1 mM N-ethyl maleimide, 5 mM phenylmethylsulfonyl fluoride, and 2 mM EDTA (ethylenediaminetetraacetic acid). Homogenates was incubated for 2 hours at 4°C, with constant agitation, after 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) was added to 0.6%. Rat gastric IF-cobalamin beads were prepared as previously described. 13 Detergent extracts were centrifuged at 4°C for 40 minutes at 40 000g, and supernatant aliquots containing 100 mg total protein were made 5 mM CaCl 2 and incubated with 20 L rat IF-cobalamin beads overnight at 4°C. The beads were washed 3 times in homogenization buffer without EDTA containing 0.6% CHAPS, boiled in gel-loading buffer, and subjected to reducing SDS-PAGE and immunoblotting as described (see "AMN expression analysis").
For immunohistochemistry, sections of normal and affected dog kidney cortex were fixed by perfusion of the renal artery with phosphate-buffered 4% paraformaldehyde, sliced to 1.5-mm thickness, and immersed for 48 hours in phosphate-buffered 1% paraformaldehyde. Thin sectioning and peroxidase-labeled immunostaining for light microscopy was performed as previously described. 16 Primary antibody was a previously described 13, 16 rabbit polyclonal anti-canine cubilin serum (1:4000) that did not crossreact with AMN. None of the anti-human, anti-mouse, or anti-canine AMN peptide antisera produced to date detected AMN specifically in canine tissue sections. Stained tissues were examined by light microscopy (Leica DMR microscope with 40ϫ/0.70 numerical aperture objective attached to a Leica DFC320 camera [Leica Microsystems, Wetzlar, Germany]). Images were produced digitally with Leica DFCT Twain 6.1.0 acquisition software and Adobe Photoshop 8.0 (Adobe Systems, San Jose, CA).
Mutation analysis in transfected CHO cells
Open reading frames of normal canine AMN and c.1113_1145del AMN cDNAs were amplified by PCR from plasmid templates using primers that incorporated HindIII recognition sites, cloned into the pCR 2.1-TOPO plasmid (Invitrogen, Carlsbad, CA), and fully sequenced to confirm integrity of the insert. After digestion with HindIII, purified insert DNA was ligated into the previously described pcDNA3-5Myc plasmid expression vector. 5 Stable, double-transfected CHO lines expressing a "mini-cubilin" construct (amino acids 1-1389 of rat cubilin) and the normal or mutant canine AMN-5Myc constructs were established and maintained as described before. 10 Expression products in CHO lysates were analyzed by immunoblotting using rabbit polyclonal antibody against rat cubilin and an anti-myc antibody (Invitrogen) for AMN detection. For endo H digestion, cyanogen bromide (CNBr)-activated Sepharose 4B beads (Amersham Biosciences, Arlington Heights, IL) coupled with porcine IF-cobalamin as previously described 27 were incubated with lysates for pull-down of recombinant cubilin. The beads were washed and subjected to endo H (Roche, Indianapolis, IN) digestion as previously described 10, 12 prior to SDS-PAGE and immunoblotting.
Immunofluorescent analysis of cubilin-expressing CHO cell lines transfected with normal or mutant AMN was performed on living, nonpermeabilized cells as previously described. 10 Briefly, living cells were incubated for 90 minutes at 4°C with a polyclonal rabbit antibody against rat cubilin (diluted to 10 g/mL in growth medium) and then fixed in 10 mM phosphate-buffered saline (PBS) containing 4% formaldehyde for 1 hour at 4°C. Finally, the cells were incubated for 1 hour at room temperature with Alexa Fluor 488-labeled goat antirabbit antibody (Molecular Probes, Eugene, OR) diluted 1:200. Stained cells were examined by laser scanning confocal fluorescence microscopy under water (Zeiss LSM 510 confocal system attached to an Axiovert microscope with a 63ϫ/1.2 numeral aperture plan C-Apochromat objective and optical magnification of 63 ϫ 10 [Carl Zeiss, Oberkochen, Germany]). Images were produced digitally with Zeiss LSM 510 software and Adobe Photoshop 5.0.
Results
AMN expression analysis
The cloned full-length canine AMN cDNA (GenBank accession no. AY368152) was 77% GC and composed of a 15-bp 5Ј-untranslated region (UTR), 1374 bp of open reading frame, and 152 bp of 3Ј-UTR that included a single polyadenylation signal 11 bp 5Ј of the poly A tract. The deduced amino acid sequence of 458 residues was 73%, 66%, 65%, 38%, 34%, 33%, and 21% identical to AMN of human (NP112205), mouse (NP291081), rat (XP234547), chicken (XP421397), Xenopus lavis (AAH74152), puffer fish (Fugu chrUn:215972629-215974032; UCSC Genome Browser, August 2002 assembly) and fruit fly (NP608515), respectively. Structural features conserved among these species included the predicted signal sequence cleavage site (after Ala19); 12 cysteine residues in the mature extracellular domain with 9 clustered in a cysteine-rich domain between residues 205-253; a single, similarly placed transmembrane domain (residues 363-387 of dog AMN); and 2 copies of [FY]XNPX[FY], a well-characterized signal for ligand-independent receptor internalization via clathrin-coated pits. 32 Potential asparagine (N)-linked glycosylation sites (dog residues 35 and 39) were found within the first 40 amino acid residues of the protein in all but the chicken and fruit fly sequences.
Northern blot of canine kidney RNA revealed a single AMN transcript of about 1.5 kbp. RT-PCR demonstrated full-length AMN mRNA as expected in tissues of known CUBN expression, inclu ding kidney cortex, jejunum, and ileum ( Figure 1) . cDNA of both genes was also detected in thymus but at very low levels. In addition, AMN but not CUBN cDNA was expressed in colon, liver, pancreas, and pituitary, and CUBN but not AMN cDNA was expressed in placenta.
Western blotting with antiserum raised against an extracellular domain peptide of canine AMN (Figure 2 . PPID primers were used as a positive control for success of the RT reaction in each RNA sample (product size 0.6 kbp). Lanes: 1, kidney; 2, muscle; 3, spleen; 4, thymus; 5, liver; 6, heart; 7, lung; 8, pituitary; 9, testis; 10, cerebellum; 11, cerebrum; 12, placenta; 13, duodenum; 14, jejunum; 15, ileum; 16, colon; 17, pancreas. 
the small isoform exhibited a more acidic isoelectric point than the 2 larger species. Furthermore, the approximately 40-kDa AMN species, but not the larger ones, was detected as a soluble molecule in the supernatant fraction of canine renal cortex membranes (prior to detergent solubilization) similarly isolated by IF-cobalamin affinity chromatography (Figure 2 lane 5) . Peptide mapping of the approximately 48-kDa AMN species identified the same peptides as indicated and the additional peptides 294-318, 322-342, 343-362, 401-428, and 429-445 composing 53% of the entire mature protein, and this species reacted with the AMN antiserum directed at the intracellular tail peptide. There was insufficient material for peptide mapping of the approximately 43-kDa AMN species, but it also reacted with the AMN antiserum directed at the intracellular tail peptide (Figure 2 lane 3) . Thus, the approximately 40-kDa AMN species is apparently truncated within or just extracellular to the transmembrane domain and the approximately 48-kDa species represents the full-length, N-glycosylated form of AMN.
AMN mutation analysis
AMN cDNA was amplified by RT-PCR from kidney cortex RNA isolated from an affected dog of the GS kindred, and sequencing revealed an in-frame, 33-bp deletion in exon 10, predicting loss of 11 amino acid residues from the transmembrane domain somewhere between residues 370-382 ( Figure 3A) . The deletion end points could not be determined exactly because they occurred within each of 2 nearly perfect copies of a 24-bp direct repeat sequence separated by 9 bp. A sequence variation of the repeats allowed us to place the 5Ј deletion end point on or between nucleotides 1106-1113 of the cDNA sequence and the corresponding 3Ј deletion end point on or between nucleotides 1138-1145, and therefore, the mutation is designated c.1113_1145del. Presence of the repeat sequences suggests that the mechanism of deletion was an unequal crossover event after misalignment of the repeats during meiosis I. The same 33-bp deletion in exon 10, but no other sequence variation in exons or intronic consensus splice sites, was found in PCR products amplified from gDNA of affected dogs. Computerized transmembrane domain prediction (http://www.cbs. dtu.dk/services/TMHMM/) returned a probability of 1.0 for a transmembrane domain between amino acid residues 363 and 387 of the normal sequence, but less than 0.05 for the mutant sequence. The deletion was homozygous in 18 affected dogs, heterozygous in 8 obligate carriers, and was not seen in 224 chromosomes of unrelated healthy dogs of various breeds.
A second canine I-GS family (AS kindred; Figure 4 ) was studied in which 3 affected littermates, 2 male and 1 female born of clinically healthy parents, exhibited growth failure, methylmalonic aciduria, mild nonregenerative anemia, neutropenia, subnormal serum cobalamin concentrations, and low-molecular-weight proteinuria. Parenteral cobalamin administration produced complete remission of the clinical, hematologic, and metabolic disease in 2 of the affected dogs, even though cobalamin malabsorption and proteinuria remained. The third affected dog died at 9 months of age in a state of inappetence, weakness, and extreme emaciation before diagnosis was made. Thus, clinical features of the disorder in the AS kindred were identical to those previously reported for affected dogs of the GS kindred. 11 A KNS2 CϾT polymorphism that was in complete linkage disequilibrium with AMN alleles in the GS kindred 19 segregated with the disorder (logarithm of the odds [LOD] ϭ 1.7, ϭ 0.0) when genotyped in 11 members of the AS kindred, including the 3 affected siblings and their parents. RT-PCR amplification of RNA isolated from a renal cortex biopsy of an affected dog revealed a GϾA transition at position 3 of the cDNA sequence (c.3GϾA), thereby disrupting the Kozak consensus sequence for translation initiation 33 and obliterating a BstF5I recognition sequence ( Figure  3B ). The mutation was present in gDNA and segregated with the disease allele, as expected for an autosomal recessive disorder, in 3 affected (A/A), 2 obligate carriers (G/A), and 17 other closely related, clinically healthy dogs of the AS kindred (14 G/G and 3 G/A). The mutation was not observed in 120 chromosomes of unrelated healthy dogs of various breeds.
Two clinically healthy dogs of the AS kindred were additionally inferred from the data to be heterozygous for the c.3GϾA mutation. One of those was homozygous for the C allele of the KNS2 polymorphism, and another unaffected dog that did not carry the mutant allele at all was heterozygous at the KNS2 locus. Thus, the C allele of the KNS2 polymorphism was of sufficiently high frequency to have entered the AS pedigree on 2 haplotypes, only one of which was associated with the mutant allele.
AMN null mutations abrogate apical membrane targeting of cubilin in vivo
Full-length AMN cDNAs of mutant dogs of both kindreds were readily amplified by RT-PCR, suggesting that RNA transcription, processing, and stability were not greatly affected by the disease mutations. To determine the effect of the c.1113_1145del mutation on protein expression in kidney, the cubam complex was enriched, in bulk, by IF-cobalamin affinity chromatography from pooled fresh frozen kidney of unrelated healthy dogs and affected dogs of the GS kindred. It was evident that certain bands or spots between 37 and 50 kDa were missing from silver-stained or Western blotted 1-or 2-dimensional gels of affected dog proteins when compared with equally loaded (total protein) gels of normal dog proteins ( Figure 5A ). Proteins of healthy dogs corresponding to those missing from affected dog gels were confirmed as AMN by peptide mapping. To accommodate the small amount of tissue available from an affected dog of the AS kindred, these experiments were repeated in small-scale IF-cobalamin affinity pull-down of proteins followed by Western blot. None of the AMN proteins of normal dog kidney ( Figure 5B lane 2) were observed in affected dogs of either kindred (GS, lane 3; AS, lane 4), indicating that the amount of AMN protein participating in cubam complexes expressed by affected dogs in both kindreds was much reduced or nil at steady state and that both the c.1113_1145del and c.3GϾA AMN mutations were effectively null.
Renal proximal tubule expression of cubilin in the absence of detectable AMN expression was examined by immunohistochemistry. As demonstrated before, 16, 17 cubilin immunoreactivity was predominantly at the apical domain of the plasma membrane in proximal tubule epithelial cells of healthy dogs. In sharp contrast, cubilin immunoreactivity was found entirely in an intracellular vesicular pattern in affected dogs in both kindreds, with no detectable labeling of the apical membrane domain ( Figure 5C ). Apical membrane localization of megalin (gp330, LRP2) in proximal tubule cells was not impaired in affected dogs. 16 The AMN c.1113_1145del mutation abrogates cubilin processing and membrane targeting in transfected CHO cells
To investigate further the effects of AMN null mutations on cubilin expression, we cloned the full-length wild-type and AMN c.1113_1145del open reading frames into a previously described 5 AMN-myc expression plasmid. CHO cells already expressing a truncated construct of rat cubilin 10 were transfected with one or the other AMN construct, and stable double-transfectant cell lines were selected. AMN expression was confirmed by Western blot in both cell lines ( Figure 6C ). Cells transfected with wild-type canine AMN cDNA exhibited the expected surface expression of cubilin, as detected by fluorescent anticubilin labeling and confocal microscopy, but cells transfected with the mutant AMN cDNA did not ( Figure 6A ). Proteins from each cell line were isolated on IF-cobalamin affinity beads, subjected to endo H or mock digestion, and Western blotted with anticubilin serum ( Figure 6B ). In cells expressing wild-type canine AMN, cubilin was detected as 2 distinct bands, the larger of which did not exhibit a gel mobility shift after endo H digestion (endo H resistant) and the smaller of which migrated as a smaller species after endo H digestion (endo H sensitive). In contrast, cells expressing the c.1113-1145del mutant AMN exhibited cubilin only as a single band that comigrated with the smaller species observed in the wild-type AMN cell line and that was endo H sensitive. Thus, cubilin expressed in CHO cells in the absence of functional, wild-type AMN did not progress through the biosynthetic pathway to the stage of oligosaccharide maturation and was not trafficked efficiently to the cell surface.
Discussion
Previous characterization of canine I-GS in the GS kindred demonstrated that cubilin expressed in distal small intestinal and For personal use only. on October 4, 2017. by guest www.bloodjournal.org From proximal tubule epithelia of affected dogs does not reach the apical membrane domain and, so, cannot fulfill its endocytic function. [11] [12] [13] [14] [15] [16] [17] Endo H sensitivity of kidney cubilin indicated that it had not been exposed to the biosynthetic oligosaccharide processing enzymes of the Golgi apparatus, and limited proteolytic digestion suggested that the protein was incompletely folded. 12 Those in vivo findings are now attributable to the AMN c.1113-1145del mutation and are identical to the observations here that cubilin expressed in CHO cells expressing AMN c.1113-1145del did not reach the plasma membrane and, as indicated by endo H sensitivity, was retained in a pre-Golgi biosynthetic compartment. In contrast to AMN expression in affected dog kidney in vivo, when AMN c.1113-1145del was overexpressed in CHO cells, the mutant protein was readily detectable but was no more capable of shepherding cubilin to the cell membrane than when cells were transfected with no AMN construct. 10 The failure of apical membrane cubilin expression was demonstrated here in I-GS caused by a second AMN mutation. The AMN c.3GϾA mutation of the AS kindred obliterates the translation initiation codon and is an obvious null mutation, as further evidenced by failure to detect AMN on Western blots of AS affected dog kidney. Although the AMN c.1113-1145del gene product may be translated, it is likely that the deleted product does not fold properly in vivo and is undetectable on Western blots of kidney proteins because it is targeted for rapid degradation. Thus, in kidney of both kindreds, effectively null AMN mutations block trafficking of cubilin to the apical plasma membrane and, thereby, all cubam-mediated endocytic functions. These findings are compatible with an active quality-control function of the RER in proximal tubule cells and suggest that cubilin and AMN must interact in the RER for protein stability and to become competent for exit from RER and apical membrane targeting.
What is the genesis of 3 AMN isoforms observed on Western blots of normal dog kidney proteins? Each had an intact amino terminus and as much of extracellular domain structure as necessary for binding to cubilin during affinity isolation and reaction with anti-extracellular peptide sera. The identities of 2 were confirmed by LC/MS/MS peptide mapping, the largest representing the full-length translation product and the smallest lacking membrane anchorage and the entire intracellular domain. Alternative splicing of known exons does not explain these data. Although possible, the short isoforms are probably not simply the result of nonspecific ex vivo proteolysis because the source tissue was immediately snap frozen, a precaution that was not possible in previous studies of human cadaver kidney where the same multiple isoforms were observed. 10 Thus it appears that the successively smaller AMN isoforms were derived from progressive carboxyterminal truncation of the full-length translation product that may be due to as yet undefined posttranslational or postendocytic modifications of unknown physiologic significance. Curiously, there is a furin cleavage site in the juxtamembrane portion of the cytoplasmic domain that is conserved in the mammalian AMN proteins. Cleavage at this site would produce an isoform of the observed approximately 43 kDa and basic pI, but the catalytic domains of enzymes in the proprotein convertase family, including furin, described to date are exposed to the noncytoplasmic compartment of Golgi cisternae, secretory vesicles, and endocytic pathway vesicles and should not have access to the cytoplasmic tail of AMN.
From phylogenetic analysis it appears that AMN functions have been sufficiently important through evolution, from insects to mammals, to maintain nearly identical structural and functional components of the protein. In the genome sequence of each species where an AMN ortholog was found, a full-length CUBN ortholog was also found. However, orthologs of IF were found only in the mammalian species, so it is likely that functions other than IF-cobalamin absorption from intestine have provided a selective advantage for cubam conservation. Additionally intriguing is the apparent expression of AMN in tissues where CUBN is not, suggesting that there are as yet unsuspected AMN functions. However, despite demonstration here and elsewhere of CUBN or AMN expression in those tissues, [34] [35] [36] [37] no aspect of the I-GS phenotype in humans or dogs has yet been attributed to malfunction of cubilin or AMN in any tissue other than intestine and kidney.
In mice, tissue expression of AMN includes the extraembryonic visceral endoderm, and AMN knockout mutations cause early embryonic malformation and death. 9 Cubilin is expressed in the same early embryonic structure of mice, 37 and exposure of developing rat embryos to anticubilin antibodies causes embryonic malformations and lethality. 38 Although undefined as yet, cubilin and AMN probably collaborate in an essential endocytic function in rodent embryonic tissue that is not required or is performed by a redundant mechanism during human and canine embryogenesis. More recently, construction of mouse blastocyst chimeras rescued the lethal phenotype of Amn Ϫ/Ϫ mice and demonstrated that cubilin was not trafficked to the apical surface of cells derived from the Amn Ϫ/Ϫ embryonic stem cells in fetal and adult tissues. 39 Finally, a volume of literature demonstrates that cubilin has a functional relationship with megalin (gp330, LRP2) another large, multiligand endocytic receptor of polarized epithelia. 8, 15, 40 The 2 receptors colocalize in the apical membrane endocytic apparatus, show partial overlap of expressing tissues, and appear to collaborate in the endocytosis of certain ligands. Moreover, renal cubilin expression is impaired in megalin knockout mice, and renal expression of both receptors is impaired in the proximal tubule chloride channel (ClC-5) knockout mouse (Clcn5 Ϫ/Y ). 41 Thus, the enunciated dual-receptor concept (megalin ϩ cubilin) may still have validity if modified (megalin ϩ cubam) to recognize that cubilin expression and function rely on AMN, at least in kidney, intestine, and mouse embryonic tissues. As previously suggested, AMN may direct proper folding, apical membrane trafficking, and initial interaction of cubam with the endocytic apparatus, whereas megalin could exert an important influence elsewhere, such as on cubam recycling or endosome integrity. 40 Studies of I-GS dogs conclusively demonstrate that effective cubam expression does not occur in the absence of AMN. Cubilin and AMN thus join a small but growing group of membrane receptors that specifically rely on the accessory activity of a separate gene product for trafficking and membrane expression. 42, 43 Although studies of AMN and cubilin expression in human I-GS are not likely to be done directly, the heterologous expression system used here recapitulates the essential aspects of cubam expression, regardless of the AMN or CUBN species origin. Therefore, this system can be used to investigate interesting human AMN and CUBN mutations and to determine the molecular domains of AMN and cubilin involved in their interaction. We continue to ascertain new canine I-GS kindreds with the prospect of finding additional genes or protein interactions involved in cubam expression and function.
